Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study

Linda Ahdieh-Grant; Patrick M. Tarwater; Michael F. Schneider; Kathryn Anastos; Mardge Cohen; Ann Khalsa; Howard Minkoff; Mary Young; Ruth M. Greenblatt

doi:10.1097/01.qai.0000138160.91568.19

Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study

Linda Ahdieh-Grant, Patrick M. Tarwater, Michael F. Schneider, Kathryn Anastos, Mardge Cohen, Ann Khalsa, Howard Minkoff, Mary Young, Ruth M. Greenblatt

Medicine

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

We characterized factors and temporal trends associated with discontinuation of highly active antiretroviral therapy (HAART) among 936 HIV-infected women enrolled in the Women's Inter-agency HIV Study. A multivariate analysis of post-HAART initiation exposures found that high HIV RNA levels (relative hazard [RH] = 1.36, P < 0.001) and high depressive symptom scores (RH = 1.53, P = 0.012) were associated with HAART discontinuation. The adjusted hazard of discontinuation was higher in the 2 most recent calendar periods compared with the first (RH =1.61, P = 0.026; RH = 1.56, P = 0.074, respectively). The increasing risk of HAART discontinuation in recent calendar periods and changes in the clinical factors associated with discontinuation reflect ongoing and dynamic shifts in the approach to HAART utilization.

Original language	English (US)
Pages (from-to)	500-503
Number of pages	4
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	38
Issue number	4
DOIs	https://doi.org/10.1097/01.qai.0000138160.91568.19
State	Published - Apr 1 2005

Keywords

Antiretroviral therapy
Cohort studies
Discontinuation
HIV/AIDS

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/01.qai.0000138160.91568.19

Cite this

Ahdieh-Grant, L., Tarwater, P. M., Schneider, M. F., Anastos, K., Cohen, M., Khalsa, A., Minkoff, H., Young, M., & Greenblatt, R. M. (2005). Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes, 38(4), 500-503. https://doi.org/10.1097/01.qai.0000138160.91568.19

Ahdieh-Grant, L, Tarwater, PM, Schneider, MF, Anastos, K, Cohen, M, Khalsa, A, Minkoff, H, Young, M & Greenblatt, RM 2005, 'Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study', Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 4, pp. 500-503. https://doi.org/10.1097/01.qai.0000138160.91568.19

@article{1a300db810f34f37b37225a679d01879,

title = "Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study",

abstract = "We characterized factors and temporal trends associated with discontinuation of highly active antiretroviral therapy (HAART) among 936 HIV-infected women enrolled in the Women's Inter-agency HIV Study. A multivariate analysis of post-HAART initiation exposures found that high HIV RNA levels (relative hazard [RH] = 1.36, P < 0.001) and high depressive symptom scores (RH = 1.53, P = 0.012) were associated with HAART discontinuation. The adjusted hazard of discontinuation was higher in the 2 most recent calendar periods compared with the first (RH =1.61, P = 0.026; RH = 1.56, P = 0.074, respectively). The increasing risk of HAART discontinuation in recent calendar periods and changes in the clinical factors associated with discontinuation reflect ongoing and dynamic shifts in the approach to HAART utilization.",

keywords = "Antiretroviral therapy, Cohort studies, Discontinuation, HIV/AIDS",

author = "Linda Ahdieh-Grant and Tarwater, {Patrick M.} and Schneider, {Michael F.} and Kathryn Anastos and Mardge Cohen and Ann Khalsa and Howard Minkoff and Mary Young and Greenblatt, {Ruth M.}",

year = "2005",

month = apr,

day = "1",

doi = "10.1097/01.qai.0000138160.91568.19",

language = "English (US)",

volume = "38",

pages = "500--503",

journal = "Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study

AU - Ahdieh-Grant, Linda

AU - Tarwater, Patrick M.

AU - Schneider, Michael F.

AU - Anastos, Kathryn

AU - Cohen, Mardge

AU - Khalsa, Ann

AU - Minkoff, Howard

AU - Young, Mary

AU - Greenblatt, Ruth M.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - We characterized factors and temporal trends associated with discontinuation of highly active antiretroviral therapy (HAART) among 936 HIV-infected women enrolled in the Women's Inter-agency HIV Study. A multivariate analysis of post-HAART initiation exposures found that high HIV RNA levels (relative hazard [RH] = 1.36, P < 0.001) and high depressive symptom scores (RH = 1.53, P = 0.012) were associated with HAART discontinuation. The adjusted hazard of discontinuation was higher in the 2 most recent calendar periods compared with the first (RH =1.61, P = 0.026; RH = 1.56, P = 0.074, respectively). The increasing risk of HAART discontinuation in recent calendar periods and changes in the clinical factors associated with discontinuation reflect ongoing and dynamic shifts in the approach to HAART utilization.

AB - We characterized factors and temporal trends associated with discontinuation of highly active antiretroviral therapy (HAART) among 936 HIV-infected women enrolled in the Women's Inter-agency HIV Study. A multivariate analysis of post-HAART initiation exposures found that high HIV RNA levels (relative hazard [RH] = 1.36, P < 0.001) and high depressive symptom scores (RH = 1.53, P = 0.012) were associated with HAART discontinuation. The adjusted hazard of discontinuation was higher in the 2 most recent calendar periods compared with the first (RH =1.61, P = 0.026; RH = 1.56, P = 0.074, respectively). The increasing risk of HAART discontinuation in recent calendar periods and changes in the clinical factors associated with discontinuation reflect ongoing and dynamic shifts in the approach to HAART utilization.

KW - Antiretroviral therapy

KW - Cohort studies

KW - Discontinuation

KW - HIV/AIDS

UR - http://www.scopus.com/inward/record.url?scp=15044342299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15044342299&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000138160.91568.19

DO - 10.1097/01.qai.0000138160.91568.19

M3 - Article

C2 - 15764968

AN - SCOPUS:15044342299

SN - 1525-4135

VL - 38

SP - 500

EP - 503

JO - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

JF - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

IS - 4

ER -

Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this